Seller record · Telehealth service

Ascend Medical

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named on the weight-loss page, in the terms or in the privacy notice, which refers only to disclosing information to a pharmacy when a prescription is ordered. 1 more criterion also fails; see the table below.

At a glance

Ascend MedicalTelehealth service

5/8criteria passed

Price: Semaglutide starting package $225 and tirzepatide $240, with health coaching included
Sells: semaglutide, tirzepatide
FDA letters: None on file

Visit Ascend Medical See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A Georgia primary care, mental health and weight loss practice with clinics in the Atlanta area and virtual visits, billed through insurance, whose medical weight loss program prescribes semaglutide and tirzepatide with health coaching and optional therapy.

Operating entity Artemis Practice Services Georgia, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Ascend Medical's weight loss page; Ascend Medical's providers page
S2	Prescription gating	PASS	Ascend Medical's weight loss page
S3	Pharmacy identification	FAIL	Ascend Medical's weight loss page; Ascend Medical's terms of use page; Ascend Medical's privacy notice
S4	Compounding disclosure	NOT VERIFIED	Ascend Medical's weight loss page; Ascend Medical's terms of use page
S5	Analytical documentation	FAIL	Ascend Medical's weight loss page; Ascend Medical's terms of use page; Ascend Medical's privacy notice
S6	Business address	PASS	Ascend Medical's terms of use page; Ascend Medical's website
S7	Price disclosure	PASS	Ascend Medical's weight loss page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSBoard-certified physicians assess each patient's full health profile and prescribe weight loss medication as part of a tailored plan, and the providers page names the practice's clinicians.Source: Ascend Medical's weight loss page; Ascend Medical's providers page.

S2PASSThe steps list booking a consultation and checking eligibility first and meeting the provider second, and medication is part of the plan the provider writes at that visit.Source: Ascend Medical's weight loss page.

S3FAILNo filling pharmacy is named on the weight-loss page, in the terms or in the privacy notice, which refers only to disclosing information to a pharmacy when a prescription is ordered.Source: Ascend Medical's weight loss page; Ascend Medical's terms of use page; Ascend Medical's privacy notice.

S4NOT VERIFIEDA statement of whether the semaglutide and tirzepatide sold are compounded did not resolve, because the words compounded and FDA-approved appear on neither the weight-loss page nor the terms. The check is open.Source: Ascend Medical's weight loss page; Ascend Medical's terms of use page.

S5FAILNo certificate of analysis or lot document is published on the weight-loss page, the terms or the privacy notice.Source: Ascend Medical's weight loss page; Ascend Medical's terms of use page; Ascend Medical's privacy notice.

S6PASSAscend Medical at 619 Rankin Street NE, Atlanta, GA 30308, printed in the terms, which name Artemis Practice Services Georgia, LLC, doing business as Ascend Medical. The home page lists the same building among its clinic locations.Source: Ascend Medical's terms of use page; Ascend Medical's website.

S7PASSA starting package costs $225 with semaglutide or $240 with tirzepatide, with health coaching included. After the first eight weeks, medication is ordered per refill at a price set by vial size and billed through insurance, and self-pay options are given by phone.Source: Ascend Medical's weight loss page.

S8PASSNo FDA warning letter names Ascend Medical or Artemis Practice Services Georgia, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide, tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Ascend Medical

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.